Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brambilla, Riccardo"'
Autor:
Pisanò CA; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy., Mercatelli D; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy., Mazzocchi M; Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland., Brugnoli A; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy., Morella I; Neuroscience and Mental Health Research Institute, Division of Neuroscience, School of Biosciences, Cardiff University, Cardiff, UK., Fasano S; Neuroscience and Mental Health Research Institute, Division of Neuroscience, School of Biosciences, Cardiff University, Cardiff, UK., Zaveri NT; Astraea Therapeutics, Medicinal Chemistry Division, Mountain View, California, USA., Brambilla R; Neuroscience and Mental Health Research Institute, Division of Neuroscience, School of Biosciences, Cardiff University, Cardiff, UK.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., O'Keeffe GW; Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland., Neubig RR; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, USA., Morari M; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2023 Apr; Vol. 180 (7), pp. 927-942. Date of Electronic Publication: 2022 Jan 12.
Autor:
Ruiz-DeDiego I; Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain., Fasano S; Neuroscience and Mental Health Research Institute (NMHRI), Neuroscience Division, School of Biosciences, Cardiff University, Cardiff, United Kingdom., Solís O; Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain., Garcia-Montes JR; Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain., Brea J; Instituto de Farmacia Industrial, Fac de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación CIMUS, Universidad de Santiago de Compostela, Santiago de Compostela, Spain., Loza MI; Instituto de Farmacia Industrial, Fac de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación CIMUS, Universidad de Santiago de Compostela, Santiago de Compostela, Spain., Brambilla R; Neuroscience and Mental Health Research Institute (NMHRI), Neuroscience Division, School of Biosciences, Cardiff University, Cardiff, United Kingdom., Moratalla R; Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain. moratalla@cajal.csic.es.; CIBERNED, Instituto de Salud Carlos III, Madrid, Spain. moratalla@cajal.csic.es.
Publikováno v:
Scientific reports [Sci Rep] 2018 Oct 18; Vol. 8 (1), pp. 15381. Date of Electronic Publication: 2018 Oct 18.
Autor:
Bastide MF; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Meissner WG; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France., Picconi B; Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy., Fasano S; Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy., Fernagut PO; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Feyder M; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Francardo V; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden., Alcacer C; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden., Ding Y; Department of Neurology, Columbia University, New York, USA., Brambilla R; Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy., Fisone G; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Jon Stoessl A; Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada., Bourdenx M; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Engeln M; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Navailles S; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., De Deurwaerdère P; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Ko WK; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Simola N; Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy., Morelli M; Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy., Groc L; Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France., Rodriguez MC; Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain., Gurevich EV; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Quik M; Center for Health Sciences, SRI International, CA 94025, USA., Morari M; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy., Mellone M; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy., Gardoni F; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy., Tronci E; Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy., Guehl D; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France., Tison F; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France., Crossman AR; Motac Neuroscience Ltd, Manchester, UK., Kang UJ; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden., Steece-Collier K; Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA., Fox S; Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada., Carta M; Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy., Angela Cenci M; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden., Bézard E; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: erwan.bezard@u-bordeaux.fr.
Publikováno v:
Progress in neurobiology [Prog Neurobiol] 2015 Sep; Vol. 132, pp. 96-168. Date of Electronic Publication: 2015 Jul 21.
Autor:
Marti M; Department of Experimental and Clinical Medicine, Section of Pharmacology, University of Ferrara and National Institute of Neuroscience, 44100 Ferrara Italy., Rodi D, Li Q, Guerrini R, Fasano S, Morella I, Tozzi A, Brambilla R, Calabresi P, Simonato M, Bezard E, Morari M
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2012 Nov 14; Vol. 32 (46), pp. 16106-19.
Autor:
Fasano S; Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, Lund 221 84, Sweden., Bezard E, D'Antoni A, Francardo V, Indrigo M, Qin L, Doveró S, Cerovic M, Cenci MA, Brambilla R
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2010 Dec 14; Vol. 107 (50), pp. 21824-9. Date of Electronic Publication: 2010 Nov 29.